• 2018
    Skin cancer, a new, hope-inspiring treatment

    In 2015, the Pierre Fabre Group signed an international partnership with Array BioPharma, an American biotech company based in Boulder, Colorado. Aim: to develop and market a targeted oncology therapy, combining two next-generation molecules. In late 2018, the European Commission granted marketing authorization for this new treatment for adult patients suffering from advanced BRAF-mutant melanoma. 

    Notre histoire - 2018
  • 1951
  • 1959
  • 1962
  • 1965
  • 1970
  • 1974
  • 1979
  • 1990
  • 1999
  • 2005
  • 2010
  • 2013
  • 2015
  • 2018